These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 3344274)

  • 1. Microwave--drug interactions in the cholinergic nervous system of the mouse.
    Monahan JC
    Prog Clin Biol Res; 1988; 257():309-26. PubMed ID: 3344274
    [No Abstract]   [Full Text] [Related]  

  • 2. The interaction between beta-phenylethylamine and agents which affect the cholinergic nervous system on locomotor activity and toxicity in mice.
    Jackson DM
    Arzneimittelforschung; 1974 Jan; 24(1):24-7. PubMed ID: 4406104
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of oxiracetam on cognition and brain cholinergic mechanisms.
    Pepeu G; Spignoli G
    Clin Neuropharmacol; 1986; 9 Suppl 4():298-300. PubMed ID: 3567945
    [No Abstract]   [Full Text] [Related]  

  • 4. On the interaction of drugs with the cholinergic nervous system--V. Characterization of some effects induced by physostigmine in mice: in vivo and in vitro studies.
    Maayani S; Egozi Y; Pinchasi I; Sokolovsky M
    Biochem Pharmacol; 1978 Jan; 27(2):203-11. PubMed ID: 623676
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological evaluation of the cholinergic system in progressive supranuclear palsy.
    Litvan I; Blesa R; Clark K; Nichelli P; Atack JR; Mouradian MM; Grafman J; Chase TN
    Ann Neurol; 1994 Jul; 36(1):55-61. PubMed ID: 8024262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinergic mediation of motor effects of ethanol in rats.
    Pohorecky LA; Makowski E; Newman B; Rassi E
    Eur J Pharmacol; 1979 Apr; 55(1):67-72. PubMed ID: 436943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methodological problems in evaluating the role of cholinergic mechanisms in behavior.
    Weiss B; Heller A
    Fed Proc; 1969; 28(1):135-46. PubMed ID: 4974735
    [No Abstract]   [Full Text] [Related]  

  • 8. On some relationships between gamma-aminobutyric acid (GABA) and the cholinergic mechanisms in electric convulsions.
    Lazarova M; Roussinov K
    Acta Physiol Pharmacol Bulg; 1977; 3(4):37-43. PubMed ID: 27058
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence for a direct cholinergic involvement in the scopolamine-induced amnesia in monkeys: effects of concurrent administration of physostigmine and methylphenidate with scopolamine.
    Bartus RT
    Pharmacol Biochem Behav; 1978 Dec; 9(6):833-6. PubMed ID: 106402
    [No Abstract]   [Full Text] [Related]  

  • 10. Cholinergic and dopaminergic involvement in phenobarbital-induced locomotor activity in mice.
    Waters DH; Walczak D
    Neuropharmacology; 1980 Jun; 19(6):543-7. PubMed ID: 7402444
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of low-intensity microwave radiation on body weight, spontaneous activity and blood values in mice in a long-term experiment].
    Kössler F; Lange F; Kupfer J; Rothe R
    Z Gesamte Hyg; 1981; 27(1):44-7. PubMed ID: 7269675
    [No Abstract]   [Full Text] [Related]  

  • 12. Invited discussion: postreinforcement synchronization and the cholinergic system.
    Marczynski TJ
    Fed Proc; 1969; 28(1):132-4. PubMed ID: 4303450
    [No Abstract]   [Full Text] [Related]  

  • 13. Cholinergic manipulations in the rat basolateral amygdaloid nucleus on locomotor activity induced by amphetamine.
    Gómez MN; Campos HA
    Brain Res; 1987 Feb; 404(1-2):304-6. PubMed ID: 3567573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood glucose and brain function: interactions with CNS cholinergic systems.
    Stone WS; Cottrill KL; Walker DL; Gold PE
    Behav Neural Biol; 1988 Nov; 50(3):325-34. PubMed ID: 3202815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of some drugs on the higher nervous activity in man. An interaction of physostigmine (1.0 mg) and scopolamine (0.6 mg applied 15 and 30 minutes after physostigmine). Part LV.
    Hrbek J; Macáková J; Komenda S; Siroká A; Hrbek J; Rypka M
    Acta Univ Palacki Olomuc Fac Med; 1986; 115():31-72. PubMed ID: 2951975
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of physostigmine on the inhibitory action of scopolamine in man.
    Hrbek J; Komenda S; Sirokã A; Macãkovã J
    Act Nerv Super (Praha); 1971; 13(3):199-200. PubMed ID: 4941431
    [No Abstract]   [Full Text] [Related]  

  • 17. On acute effects of some drugs on the higher nervous activity in man. Scopolamine (0.6 mg), physostigmine (1.0 mg) and their interaction. Part LIII.
    Hrbek J; Macáková J; Komenda S; Siroká A; Rypka M
    Acta Univ Palacki Olomuc Fac Med; 1985; 112():185-226. PubMed ID: 2938435
    [No Abstract]   [Full Text] [Related]  

  • 18. [Relationship between the hypotensive effect of clonidine and the central cholinergic nervous system].
    Guan YY; Ma CG; Xu SY
    Yao Xue Xue Bao; 1982 Nov; 17(11):815-20. PubMed ID: 6301214
    [No Abstract]   [Full Text] [Related]  

  • 19. Scopolamine administered before and after training impairs both contextual and auditory-cue fear conditioning.
    Rudy JW
    Neurobiol Learn Mem; 1996 Jan; 65(1):73-81. PubMed ID: 8673409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the interaction of drugs with the cholinergic nervous system--IV. Tolerance to oxotremorine in mice: in vivo and in vitro studies.
    Maayani S; Egozi Y; Pinchasi I; Sokolovsky M
    Biochem Pharmacol; 1977 Sep; 26(18):1681-7. PubMed ID: 901587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.